Table 5.
Differentially expressed genes in melanoma tumors responding to RAF265 compared with those expressed in melanoma tumors not responding to RAF265
Gene symbol | Description |
P value responder/ nonresponder |
Fold change/RAF265 responder/nonresponder |
---|---|---|---|
SERPINA3** | Serpin peptidase inhibitor clade A | 0.037 | 5.77 |
CNTN1** | Contactin 1 | 0.018 | 5.04 |
SLC25A27 | Solute carrier family25 member27 | 0.012 | 4.78 |
MPPED2** | Metallophosphoesterase domain containing 2 | 0.024 | 4.66 |
ANO4 | Anoctamin 4 | 0.007 | 4.07 |
RBMY2EP | RNA-binding motif protein, Y-linked, 2E | 0.012 | 3.94 |
TMEM47** | Transmembrane protein 47 | 0.005 | 3.91 |
ST8SIA6 | ST8α-N-acetyl-neuraminide-α2,5-sialy-transferase | 0.023 | 3.87 |
NEO1** | Neogenin homolog 1 | 0.013 | 3.84 |
GPC3** | Glypican3 | 0.006 | 3.50 |
SLC26A2** | Solute carrier family 26 member 2 | 0.034 | 3.42 |
TXNDC13** | Thioredoxin domain containing 13 | 0.015 | 3.15 |
PDGFD** | Platelet-derived growth factor D | 0.011 | 3.14 |
ETNK2 | Ethanolamine kinase 2 | 0.032 | 3.12 |
GNG7 | Guanine nucleotide binding protein gamma 7 | 0.001 | 3.09 |
AMD1 | Adenosylmethionine decarbosylase 1 | 0.011 | 3.07 |
ZNF320 | Zinc finger binding protein 320 | 0.011 | 2.99 |
ANGPTL7 | Angiopoietin-like 7 | 0.0002 | 2.98 |
NPAL3 | NPA-like domain containing 3 | 0.029 | 2.97 |
F5 | Coagulation factor V | 0.015 | 2.95 |
CTSF** | Cathepsin F | 0.0002 | 2.91 |
CTGF** | Connective tissue growth factor | 0.028 | 2.90 |
RAPGEF4 | Rap guanine nucleotide exchange factor | 0.011 | 2.88 |
ABCA5 | ATP-binding cassette,A5 | 0.013 | 2.77 |
RPL15 | Ribosomal protein L15 | 0.023 | 2.75 |
GLT8D4 | Glycosyltransferase 8 domain containing 4 | 0.013 | 2.74 |
WDR17 | WD repeat domain 17 | 0.039 | 2.74 |
F2R* | Coagulation factor 2 receptor | 0.039 | 2.70 |
SPRY2** | Sprouty homolog 2 | 0.039 | 2.70 |
SCRG1** | Scrapie responsive protein 1 | 0.015 | 2.64 |
MBNL2 | Muscleblind-like 2 | 0.034 | 2.63 |
PCMTD2 | Protein-D-aspartate-O-methyltransferase | 0.023 | 2.62 |
KCNJ10** | Potassium inwardly rectifying channel J10 | 0.024 | 2.57 |
CRHR1** | Corticotropin releasing hormone receptor 1 | 0.026 | 2.56 |
CD44 | CD44 molecule (Indian Blood Group) | 0.006 | 2.49 |
CD59 | Complement regulatory protein | 0.038 | 2.46 |
C5orf26 | Chromosome 5 open reading frame 26 | 0.019 | 2.42 |
NR1D2 | Nuclear receptor subfamily1 D2 | 0.011 | 2.42 |
GAPDHS | Glyceraldehyde-3-phosphate dehydrogenase | 0.032 | 2.39 |
SNX7 | Sorting nexin 7 | 0.030 | 2.35 |
FBXO32 | F-box protein 32 | 0.042 | 2.34 |
FOXR2 | Forkhead box R2 | 0.037 | 2.31 |
SPATA13 | Spermatogenesis associated 13 | 0.037 | 2.29 |
SLITRK6 | SLIT, NTRK-like family member 6 | 0.039 | 2.28 |
ARID5B | AT-rich interactive domain 5B | 0.013 | 2.28 |
TAPT1 | Transmembrane anterior/posterior transformation | 0.032 | 2.27 |
MCTP1 | Multiple C2 domains, transmembrane 1 | 0.031 | 2.27 |
MRAP2 | Melanocortin 2 receptor accessory protein 2 | 0.033 | 2.25 |
CDK6** | Cyclin-dependent kinase 6 | 0.046 | 2.24 |
PDZRN3 | PDZ domain containing ring finger 3 | 0.036 | 2.24 |
C20orf30 | Chromosome 20 ORF 30 | 0.033 | 2.23 |
ZCCHC14 | Zinc finger CCHC domain containing 14 | 0.013 | 2.21 |
RPL22 | Ribosomal protein L22 | 0.019 | 2.20 |
TSC22D1 | TSC22 domain family member 1 | 0.001 | 2.19 |
PLCB1** | Phospholipase C beta 1 | 0.032 | 2.18 |
CYP39A1 | Cytochrome P450 family 39,A1 | 0.013 | 2.15 |
CAMLG | Calcium-modulating ligand | 0.014 | 2.13 |
AIG1 | Androgen induced 1 | 0.037 | 2.11 |
AQP7P1 | Aquaporin 7 pseudogene 1 | 0.025 | 2.10 |
ACSS2 | Actyl-CoA synthetase short-chain 2 | 0.006 | 2.09 |
HPS5 | Hermansky-Pudlak syndrome 5 | 0.006 | 2.08 |
CDC42EP3** | CDC42 effector protein 3 | 0.021 | 2.08 |
ANKRD10 | Ankyrin repeat domain 10 | 0.004 | 2.08 |
ZNF844 | Zinc finger protein 844 | 0.015 | 2.07 |
PIGA** | Phosphatidylinositol glycan anchor biosynthesis A | 0.035 | 2.07 |
AMFR | Autocrine motility factor receptor | 0.043 | 2.06 |
FAM172A | Family with sequence similarity 172A | 0.027 | 2.04 |
ENDOD1** | Endonuclease domain containing 1 | 0.037 | 2.04 |
TBC1D19 | TBC1 domain family member 19 | 0.011 | 2.03 |
SLC12A2** | Solute carrier family 12A2 | 0.039 | 2.03 |
JMY** | Junction-mediating and regulatory protein | 0.037 | 2.01 |
FLJ26056 | Hypothetical protein LOC375127 | 0.048 | 0.50 |
LOC728212 | Hypothetical LOC 728212 | 0.038 | 0.48 |
KNTC1** | Kinetochore associated 1 | 0.012 | 0.47 |
DKFZP434L187 | Hypothetical LOC 26082 | 0.031 | 0.46 |
WDHD1** | WD repeat & HMG-box DNA Binding Protein1 | 0.006 | 0.46 |
MERTK** | c-mer proto-oncogene tyrosine kinase | 0.001 | 0.46 |
DKFZP434B061 | DKFZP434B061 protein | 0.038 | 0.45 |
NOSTRIN | Nitric oxide synthase trafficker | 0.032 | 0.38 |
NOTE. **, indicates those genes also detected as differentially expressed between responders and nonresponders by GSEA.